Literature DB >> 17495358

Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas.

Stefano Serra1, Sima Salahshor, Mosa Fagih, Firouzeh Niakosari, Jasim M Radhi, Runjan Chetty.   

Abstract

CONTEXT: Solid pseudopapillary tumors of the pancreas are rare and have recently been shown to harbor mutations of the beta-catenin gene with resultant nuclear localization of beta-catenin protein to the nucleus. Moreover, there is a close relationship between beta-catenin and E-cadherin.
OBJECTIVE: To explore the protein expression of E-cadherin in a series of solid pseudopapillary tumors of the pancreas. PARTICIPANTS: Eighteen cases of solid pseudopapillary tumors of the pancreas.
DESIGN: The cases were studied using a tissue microarray that was constructed as follows: for each case, 4 to 14 cores measuring 1.0 mm each were drilled from the blocks. Tissue cores from normal pancreas were used as controls and for orientation purposes. MAIN OUTCOME MEASURES: The slides were stained with the following commercially available antibodies: CD10, CD56, vimentin, alpha-1-antitrypsin, alpha-1-antichymotrypsin, neuron-specific enolase, chromogranin, synaptophysin, beta-catenin and E-cadherin.
RESULTS: All the tumors were CD10, vimentin, alpha-1-antitrypsin and alpha-1-antichymotrypsin diffusely positive (50% or more of the tumor cells staining) and CD56 showed focal positivity in all cases with 5-10% of tumor cells displaying immunolabeling. All cases were negative for chromogranin and synaptophysin. All 18 cases displayed cytoplasmic and nuclear localization of beta-catenin protein. Similarly, E-cadherin protein was localized to the nucleus in all 18 cases, with loss of the characteristic membranous decoration of cells.
CONCLUSION: This study is the first demonstration of aberrant nuclear localization of E-cadherin protein in solid pseudopapillary tumors of the pancreas. Whilst the exact mechanism is not know and nuclear E-cadherin is not related to tumor aggression, this staining pattern may be of diagnostic value in concert with beta-catenin staining.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17495358

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  9 in total

Review 1.  E-cadherin's dark side: possible role in tumor progression.

Authors:  Fausto J Rodriguez; Laura J Lewis-Tuffin; Panos Z Anastasiadis
Journal:  Biochim Biophys Acta       Date:  2012-03-13

2.  Circulating tumor cells as a window on metastasis biology in lung cancer.

Authors:  Jian-Mei Hou; Matthew Krebs; Tim Ward; Robert Sloane; Lynsey Priest; Andrew Hughes; Glen Clack; Malcolm Ranson; Fiona Blackhall; Caroline Dive
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 3.  Solid Pseudopapillary Neoplasms of the Pancreas: A Surgical and Genetic Enigma.

Authors:  Leon Naar; Despoina-Amalia Spanomichou; Aikaterini Mastoraki; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

4.  Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma.

Authors:  Hanna Ronkainen; Saila Kauppila; Pasi Hirvikoski; Markku H Vaarala
Journal:  J Exp Clin Cancer Res       Date:  2010-01-14

5.  Altered expression of β-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma.

Authors:  Rahul Bhagat; C S Premalata; V Shilpa; V R Pallavi; G Ramesh; C R Vijay; Lakshmi Krishnamoorthy
Journal:  Tumour Biol       Date:  2013-04-19

Review 6.  Protein mislocalization: mechanisms, functions and clinical applications in cancer.

Authors:  Xiaohong Wang; Shulin Li
Journal:  Biochim Biophys Acta       Date:  2014-04-04

7.  An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt/β-catenin-elicited promotion of the cancer stem cell phenotype.

Authors:  Y-J Su; Y-W Chang; W-H Lin; C-L Liang; J-L Lee
Journal:  Oncogenesis       Date:  2015-06-15       Impact factor: 7.485

8.  High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors.

Authors:  Aline Ramos Maia Lobba; Ana Claudia Oliveira Carreira; Otto Luiz Dutra Cerqueira; André Fujita; Carlos DeOcesano-Pereira; Cynthia Aparecida Bueno Osorio; Fernando Augusto Soares; Pranela Rameshwar; Mari Cleide Sogayar
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

9.  E-cadherin can limit the transforming properties of activating β-catenin mutations.

Authors:  David J Huels; Rachel A Ridgway; Sorina Radulescu; Marc Leushacke; Andrew D Campbell; Sujata Biswas; Simon Leedham; Stefano Serra; Runjan Chetty; Guenievre Moreaux; Lee Parry; James Matthews; Fei Song; Ann Hedley; Gabriela Kalna; Fatih Ceteci; Karen R Reed; Valerie S Meniel; Aoife Maguire; Brendan Doyle; Ola Söderberg; Nick Barker; Alastair Watson; Lionel Larue; Alan R Clarke; Owen J Sansom
Journal:  EMBO J       Date:  2015-08-03       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.